Navigation Links
OPKO Completes Acquisition Of PROLOR Biotech
Date:8/29/2013

as risks inherent in funding, developing and obtaining regulatory approvals of new, commercially-viable and competitive products and treatments. In addition, forward-looking statements may also be adversely affected by general market factors, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new products and indications, manufacturing issues that may arise, and patent positions and litigation, among other factors. The forward-looking statements contained in this press release may become outdated over time. OPKO and PROLOR do not assume any responsibility for updating any forward-looking statements.OPKO CONTACT:

PROLOR CONTACT:

PROLOR MEDIA:Steve D. Rubin, Executive

Shai Novik, President

Barbara LindheimVice President - Administration

PROLOR Biotech, Inc.

BLL Partners, LLCJuan F. Rodrigez, Chief Financial Officer

+1 866 644-7811

+1 212 584-2276 +1 305-575-4100

shai@prolor-biotech.com 

blindheim@bllbiopartners.comOPKO Heath, Inc.
'/>"/>

SOURCE OPKO Health, Inc.; PROLOR Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sleep Nation, Inc. Completes 43 Acquisitions
2. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
3. InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
4. Immune Pharmaceuticals Completes Merger with EpiCept Corporation
5. MicuRx Completes $25 Million Series B Financing
6. Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.
7. ULURU Inc. Completes Redemption Of Preferred Stock
8. HedgePath Pharmaceuticals, Inc. Completes Reorganization Plan with Commonwealth Biotechnologies
9. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
10. Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb
11. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Sept. 2, 2015  Seeger Weiss LLP is reporting ... will commence October 13, 2015. Since ... fast-track approval program, Zimmer NexGen knee implant surpassed FDA ... that companies provide evidence that the product is substantially ... to gain permissions. In 2001, Zimmer ...
(Date:9/2/2015)... Sept. 2, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... Chief Financial Officer of Neurocrine Biosciences, will be presenting ... New York City . The live ... ET (8:25am PT).  The presentation will be webcast and ... http://www.neurocrine.com .   Listeners are encouraged to ...
(Date:9/2/2015)... -- Demers Ambulances is proud to announce it has signed ... the states of Mississippi , ... "This will enable Demers to effectively meet the ... Vice-President for Demers Ambulances. "Emergency Equipment Professionals has three service ... Alabama , giving them a strategic advantage. Local ...
Breaking Medicine Technology:Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2Demers Ambulances has named Emergency Equipment Professionals (EEP) Inc. as their dealer for the states of MS, AL and TN 2
... call Monday, March 10, 2008 at 8:30am, NEW ... ) today announced top-line results from its SUN-MICRO,Phase 3 ... nephropathy. The Company announced that this Phase 3 clinical,trial ... which was to,increase the proportion of patients that achieve ...
... Hardening Affects of the,Devastating Disease, CHICAGO, March ... the effects of an anti-cancer drug to treat,patients ... leads to hardening and tightening of the skin ... in the United States and,can often attack the ...
Cached Medicine Technology:Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 2Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 3Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 4Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients 2
(Date:9/3/2015)... ... ... ProScrub is a set of automated tools that allow Final Cut Pro ... without the use of keyframes. Utilize ProScrub's powerful sliders to determine the number ... to energetic video productions. ProScrub is a Final Cut Pro X ...
(Date:9/3/2015)... ... September 03, 2015 , ... AvePoint, the ... AvePoint Perimeter Service Pack (SP) 4 – AvePoint’s solution for facilitating two-way collaboration ... “KMWorld 2015 Trend-Setting Product”. This is the fifth consecutive year an AvePoint ...
(Date:9/3/2015)... ... 2015 , ... Representatives with State Farm Agent EJ Roberts ... Gulf Babypalooza on September 19, 2015. , “We will be providing information to ... We will be discussing setting up college funds, offering information specific to their ...
(Date:9/3/2015)... ... September 03, 2015 , ... When looking at the types of people who have ... of two categories: those that have a weak appetite or those that have a fast ... to gain weight, CB-1 Weight Gainer gives three tips for slowing down metabolism. , The ...
(Date:9/3/2015)... , ... September 03, 2015 , ... James Earl Jones ... workplace wellness. In this episode, James Earl Jones will introduce a segment that discusses ... unhealthy workplace and how workplace wellness can be fostered in any working environment. , ...
Breaking Medicine News(10 mins):Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2
... Lay, the founder of Enron, who was admitted at the ... the early morning due to a heart attack//. ... had succumbed to his illness just months before his impending ... founder of the Enron Corp. was convicted on 10 counts ...
... in New Brunswick, New Jersey have reported that breast ... wetting //as children since they seem to have a ... inferring that breast-feeding protects against bed-wetting and our results ... added that there was sufficient evidence that bed-wetting can ...
... an important move that will benefit poor patients, the Centre ... prestigious All India Institute// of Medical Sciences (AIIMS). ,The ... was taken at a meeting of the AIIMS Institute Body ... to be rolled back., ,"The Union Health Ministry has ...
... attractive sachets is fast replacing the traditional paan in Pakistan, ... that both are banned, says a media report. ,In ... gutka, is being marketed daily. ,The government ... "too great". "In fact it is registered as an important ...
... of relieving pain, say researchers from the University College London. ... understand the behavior of pain receptors within cells. ... effect. Scientists rated the benefits of heat for pain relief ... turned off at the molecular level, when exposed to heat. ...
... (MIMR) have developed a new machine, named near-infrared spectroscopy, ... ,Although it was the first of its ... fluctuating BP and brain oxygen levels of a preterm ... of Medical Research (MIMR) are carrying out studies to ...
Cached Medicine News:Health News:Preterm Babies Benefited from a New NI Spectroscopy 2
... is a CO2 laser system with ... Its functions in continuous and super-pulsed ... extreme laser intervention delicacy. Excellent as ... it comes with a large LCD ...
Auto Refkeratomoeter...
Developed to meet the infusion needs in NICU, Anesthesia and Critical Care, the AUTO SYRINGE AS50 Infusion Pump delivers precise, controlled infusions....
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology....
Medicine Products: